Salupharma

Salupharma is a specialty pharmaceutical company based in the Netherlands that focuses on the development, registration, and marketing of medicines for niche markets and unmet medical needs. The company specializes in providing access to essential medications that may not be commercially attractive for larger pharmaceutical firms, particularly in therapeutic areas like endocrinology. In 2020, Salupharma was acquired by Ace Pharmaceuticals to strengthen their combined portfolio of orphan drugs and essential medicines. The company is known for its Salu-branded products, including hydrocortisone and prednisolone formulations, which serve patients with rare or specific medical requirements.